DELCATH SYSTEMS, INC.: Kaufman Daniel Louis amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Delcath Systems Inc. saw insider Daniel Louis Kaufman amend his Schedule 13G beneficial ownership filing with the SEC under accession number 0001099910-26-000307. The amended 13G updates Kaufman's reported stake in the medical device maker, though the filing did not disclose a change in share count or percentage. Schedule 13G amendments are typically filed by passive investors and signal shifts in large holders' positions that can draw scrutiny from other shareholders. Investors will watch for further 13G or 13D filings to confirm whether Kaufman's position is growing or being trimmed.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Delcath Systems, Inc., Kaufman Daniel Louis